ENVALITH
Genky DrugStores株式会社 logo

Genky DrugStores Co.,Ltd.

9267Prime MarketRetail Trade

Genky DrugStores株式会社 logo
Genky DrugStores Co.,Ltd.9267
Reference Indicators

Market Cap

1,079¥100M

P/E (Forecast)

P/B

1.7x

Dividend Yield (Forecast)

0.37%

ROE

13.8%

EV/EBITDA

7.7x
Financial Summary
Unit: ¥M
Item
2022Jun 2022
2023Jun 2023
2024Jun 2024
2025Jun 2025
2026Jun 2026
Net Sales
154,639169,059184,860200,786220,638
Cost of Sales
123,685134,505147,239159,896175,715
Gross Profit
30,95434,55337,62040,88944,923
SG&A Expenses
25,27927,84428,60531,23133,938
Operating Income
5,6756,7099,0159,65810,985
Non-operating Income
789776669841996
Non-operating Expenses
377406416600823
Ordinary Income
6,0877,0799,2689,89911,157
Extraordinary Income
612484
Extraordinary Losses
1038746949
Pre-tax Income
6,0836,7048,8039,90211,153
Income Taxes
1,6631,9392,4782,8363,277
Net Income
4,4204,7646,3247,0667,875
EBITDA
10,26711,66414,58115,95018,118
Gross Margin
20.0%20.4%20.4%20.4%20.4%
Operating Margin
3.7%4.0%4.9%4.8%5.0%
ROA
4.6%4.5%5.6%5.5%5.4%
ROE
12.9%12.4%14.5%14.2%13.8%